Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study
Clinical trial NCT04384497 · COMPLETED
Trial details
- NCT number
- NCT04384497
- Sponsor
- Joakim Dillner
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-07
- Primary completion
- 2020-06-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.